CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	155,978,020
Beginning Balance	$ (741,814)	$ (807,877)
Net income	34,800	34,741
Total other comprehensive income (loss)	(11)	209
Dividends on common stock	(31,948)	(31,764)
Restricted stock grants	0	0
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	(3,405)	(2,659)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options		(12,633)
Exercise of stock options		12,105
Stock-based compensation	$ 3,314	2,106
Ending Balance (in shares)	157,419,093
Ending Balance	$ (739,064)	$ (805,772)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	155,978,020	154,840,902
Beginning Balance	$ 15,598	$ 15,484
Restricted stock grants (in shares)	1,745,000	1,290,000
Restricted stock grants	$ 175	$ 129
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting (in shares)	(303,927)	(197,421)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	$ (31)	$ (20)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options (in shares)		(1,012,249)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options		$ (101)
Exercise of stock options (in shares)		1,055,315
Exercise of stock options		$ 106
Ending Balance (in shares)	157,419,093	155,976,547
Ending Balance	$ 15,742	$ 15,598
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	11,384	5,092
Restricted stock grants	(175)	(129)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting	(3,374)	(2,639)
Withholding of shares as payment of payroll tax liabilities in connection with exercise of stock options		(12,532)
Exercise of stock options		11,999
Stock-based compensation	3,314	2,106
Ending Balance	11,149	3,897
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(755,883)	(812,380)
Net income	34,800	34,741
Dividends on common stock	(31,948)	(31,764)
Ending Balance	(753,031)	(809,403)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(12,913)	(16,073)
Total other comprehensive income (loss)	(11)	209
Ending Balance	$ (12,924)	$ (15,864)